D Marot

D Marot

Auto-generated profile, based on publicly available information

D Marot

UMR 8121 CNRS, Vectorologie et Transfert de gènes, Institut Gustave Roussy, Villejuif Cedex, France

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2000
Verified
Journal Article
Closed access
FPF Le Page
F Le Page
VRV Randrianarison
V Randrianarison
DMD Marot
D Marot
JCJ Cabannes
J Cabannes
MPM Perricaudet
M Perricaudet
ASA Sarasin
A Sarasin

6 October 2005 in Gene Therapy
Verified
Journal Article
Open access
PDF file
DMD Marot
D Marot
POP Opolon
P Opolon
SBS Brailly-Tabard
S Brailly-Tabard
NEN Elie
N Elie
VRV Randrianarison
V Randrianarison
MPM Perricaudet
M Perricaudet
The BRCA1 (breast cancer 1) breast cancer susceptibility gene is recognized as responsible for most familial breast and ovarian cancers and is suggested to be a tissue-specific tumor suppressor gene. In this report, we investigated the tissue specificity of tumor inhibitory activities induced by a recombinant adenovirus coding for wild-type BRCA1 (wtAdBRCA1). We demonstrated a pronounced in vitro antiproliferative effect on H1299 lung and HT29 colon cells upon infection with AdBRCA1. We describe a prolonged G1 cell cycle arrest associated with a decrease in the hyperphosphorylated form of Rb, suggesting that the Rb/E2F pathway is implicated in BRCA1-induced cell growth arrest. We also observed a significant antitumor effect in these pre-established subcutaneous tumors after in situ delivery of AdBRCA1, although these two tumors do not express wt p53, and also estrogen α and β, progesterone and androgen receptors. Moreover, BRCA1 can induce a strong prolonged cell cycle arrest and apoptotic cell death but no significant antiangiogenic effect in H1299 tumors. Finally, our data indicate that intratumor administration of wtAdBRCA1 significantly inhibits growth of lung and colon steroid hormone-independent tumors.